MDT perspectives on the latest guideline recommendations for the treatment of HFrEF episode artwork

EPISODE · Mar 22, 2022 · 11 MIN

MDT perspectives on the latest guideline recommendations for the treatment of HFrEF

from touchPODCAST · host touchpodcast

touchMDT for touchCARDIO Listen to key experts from a multidisciplinary team discuss latest guideline recommendations for HFrEF therapies and how new and emerging therapies may be incorporated into clinical practice, now and in the future The multidisciplinary team Cardiology nurse specialist: Dr Carol Wade, Baltimore, USA Cardiologist: Dr Akshay Desai, Boston, USA Primary care physician: Prof. Ahmet Fuat, Darlington, UK This touchPODCAST is for HCPs only.  This activity is funded by an unrestricted independent medical education grant from Merck & Co., Inc., Boehringer Ingelheim Pharmaceuticals Inc. (BIPI) and Lilly USA, LLC (Lilly) Alliance. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchcardioime.org/multidisciplinary-team-insights-on-the-promise-of-new-and-emerging-treatment-options-for-patients-with-hfref//

Episode metadata supplied by the publisher feed · Published Mar 22, 2022

Embed this episode

Ready to play

MDT perspectives on the latest guideline recommendations for the treatment of HFrEF

0:00 11:26

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of touchPODCAST?

This episode is 11 minutes long.

When was this touchPODCAST episode published?

This episode was published on March 22, 2022.

Can I download this touchPODCAST episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!